Vision Zero Cancer and Testbed Sweden Precision Health Cancer organized two events in Almedalen 2023. Almedalen takes place each year in Sweden in the city of Visby at the island of Gotland and is the world's largest democratic meeting place for social issues.

PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.

Join us for the EU Cancer Mission Day - Ireland, advancing the fight against cancer and improving lives.

We are excited to be part of the growing DLCT (DRUP-Like Clinical Trial) Community and are looking forward to start working on the implementation of precision medicine for all patients in Europe!

Combining Expertise Across Borders to Promote Precision Cancer Medicine in Europe. PRIME-ROSE is a Horizon Europe Mission on Cancer project with 24 partners from altogether 18 European countries. Moreover, PRIME-ROSE is part of the Cancer Mission cluster of projects on Diagnosis and Treatment.

Vision Zero Cancer and Testbed Sweden Precision Health Cancer are organizing two events in Almedalen 2023. Almedalen takes place each year in Sweden in the city of Visby at the island of Gotland and is the world's largest democratic meeting place for social issues.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

In 2021, Vision Zero Cancer, Genomic Medicine Sweden (GMS) and SciLifeLab joined forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation hub that facilitates the introduction of more precise prevention and treatment in cancer care.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

PCM4EU - Podcast - #episode3 - Application of artificial intelligence, bioinformatics and mathematics for health

Great meeting with European Medicines Agency discussing the PRIME-ROSE and PCM4EU - Personalised Cancer Medicine for all EU citizens projects!

Visit the PCM4EU webbsite: Combining expertise across borders to promote Precision Cancer Medicine i Europe.

All.Can is an international multi-stakeholder not-for-profit organisation working to improve the efficiency of cancer care by focusing on what matters to patients.

The 12 of May 2023, we hosted a multi-stakeholder cancer meeting together with The Embassy of Sweden in Vienna and our co-founder Elekta. On the topic “From breakthrough to follow through in radiotherapy” in the context of the Swedish Presidency of the Council of EU and the ongoing ESTRO Congress.

Testbed Sweden Precision Health Cancer is a national collaborative project for the design and method development of precision medicine treatment studies

PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

Prevention 360 is a prestudy by Vision Zero Cancer together with AI Sweden, Informationsdriven Vård, Prevention Barnfetma and Fokus Patient.

Yesterday Ebba Hallersjö Hult met Mike Morrissey, Chief Executive, European Cancer Organisation & President, European Society of Association Executives, at the EU Beating Cancer Plan and the EU Cancer Mission conference and continued our dialogue on how Vision Zero Cancer can contribute to the Focused Topic Network of the European Cancer Organisation.

EU Beating Cancer Plan and the EU Cancer Mission – collaboration for effective and equitable implementation across Europe. Stockholm January 31st 2023